COSMOS Pharmaceutical Corporation (JP:3349) has released an update.
COSMOS Pharmaceutical Corporation reported a strong start to the fiscal year, with net sales and profits showing significant increases in the first quarter ending August 31, 2024. The company experienced a robust growth in operating profit by 28.8% and a 25.1% increase in profit attributable to owners from the same period last year. The financial forecast for the year remains positive, projecting continued growth in net sales and basic earnings per share.
For further insights into JP:3349 stock, check out TipRanks’ Stock Analysis page.